GSP Crop Science Limited — Q3 FY26 earnings call

Call held 17 Apr 2026

Management summary

GSP Crop Science reported strong financial performance for the nine months ended December 31, 2025, with revenue of ₹1,114 crores, EBITDA up 32% YoY to ₹153 crores, and PAT up 25.84% YoY to ₹75 crores. The company's strategy of focusing on innovative, patented products is yielding results, with these products now contributing 20% of revenues and offering higher margins. While geopolitical factors have increased raw material and logistics costs, GSP has largely passed these on, maintaining a positive outlook for sustainable growth.

Highlights

  • Revenue for 9 months ended Dec 31, 2025, was ₹1,114 crores.

  • EBITDA for 9 months ended Dec 31, 2025, was ₹153 crores, marking a 32% increase from last year.

  • PAT for 9 months ended Dec 31, 2025, reached ₹75 crores, up 25.84% from ₹59.6 crores last year.

  • Patented products contribute 20% of current FY26 revenues, up from 3% three years ago, offering a 20-25% gross margin premium.

  • Successfully launched 12 patented products and plans 1-2 new launches annually, including a high-potential insecticide and fungicide mixture for paddy.

Concerns

  • An exceptional item of ₹4.5 crores was recorded for additional provisions due to new labor wage code effects.

  • Middle East conflict has led to increased crude prices, raw material costs, and logistics expenses, though largely passed on to customers.

  • Potential for a 2-3 month price lag in passing on increased costs in the B2C segment.

Key financials

  1. Revenue ₹1,114 Cr
  2. EBITDA ₹153 Cr +32%YoY
  3. PAT ₹75 Cr +25.8%YoY

What they filed

Q1 FY27: revenue up 2.4%, net profit up 13.0% against the same quarter last year.

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue276 308 377 467 270 −2%402 +31%386 +2%
EBITDA3 40 42 93 13 +333%36 −10%43 +2%
Net profit-6 22 23 58 -6 +0%20 −9%26 +13%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Domestic B2B
    40% Revenue Share
  • Domestic B2C
    40% Revenue Share
  • Export
    20% Revenue Share

Guidance & targets

Revenue Mix

  • Patented Products Revenue Contribution Revenue Mix · next 3 years · High confidence 40-50%
    So, we are seeing that, going forward in the upcoming 3 years, we see that almost the growth rate that we've been experiencing will continue with that growth rate that we're currently having. So broadly, on a very high basis, almost 40% to 50% revenue will be coming from this kind of products.

    — Shail Shah

Growth Rate

  • Overall Growth Rate Growth Rate · upcoming 3 years · Medium confidence 5-7% higher than last 3 years' growth rate
    Currently, it will be difficult for us to share, but broadly, the growth rate that we've been experiencing since last 3 years, we're expecting that this or at least higher growth rate by another 5%-7% is what we're targeting for the upcoming 3 years.

    — Shail Shah

Revenue

  • Revenue at Peak Capacity Utilization Revenue · High confidence ₹1,900-2,000 crores
    So with this technicals and with the kind of mix that we have in revenues, which is we have almost 75% of our business which is coming from formulations and 25% which is technical, we see that with peak utilization, we'll be almost reaching around INR1,900 crores to INR2,000 crores.

    — Shail Shah

What to watch in Q4 FY26

Impact of El Nino on sales

next quarter
Current Management expects limited impact on paddy due to irrigation.
Target Verify if sales are affected by El Nino in Kharif season.

Why it matters

El Nino can significantly impact agricultural demand, and GSPCROP's resilience needs to be monitored.

Yes, basically, yes, definitely, forecast is El Nino. See, our as in my earlier speech, I told that we are more, our main strong area is paddy. And normally in paddy, see, 40% consumption is on paddy. And paddy is showing where the irrigation facility is there. So we are not seeing much challenges because of this El Nino effect.

Risks & concerns

  • Rising fertilizer prices impacting farmer spending

    medium

    Farmers may reduce spending on crop protection, but management sees an opportunity for increased sales of nutrition products due to fertilizer shortage.

    Analyst acknowledged

  • Middle East conflict leading to increased crude, raw material prices, and logistics costs

    medium

    Crude price increases have impacted raw material and logistics costs (shipping from China doubled), but the company has passed on 10-15% price increases to customers.

    Analyst acknowledged

  • Price lag in passing on costs in the B2C segment

    medium

    While B2B price increases are accepted, there is typically a 2-3 month lag in passing on costs in the B2C segment.

    Management acknowledged

  • El Nino forecast for Kharif season

    low

    Management believes impact on paddy, a key crop, will be limited due to irrigation facilities.

    Analyst downplayed

Q&A highlights

8 direct
Impact of El Nino on Kharif season Direct
And normally in paddy, see, 40% consumption is on paddy. And paddy is showing where the irrigation facility is there. So we are not seeing much challenges because of this El Nino effect.

Addresses a key weather-related risk for an agrochemical company, with management indicating limited impact on their core paddy business.

Asked by Shivansh Singh

Impact of rising fertilizer prices on farmer profitability and crop protection product spending Direct
See, basically, because of this, it is a huge shortage of fertilizer. And because of that, now we see nutrition product. See, we are we have a few nutrition product also. So this farmer is forced to buy this nutrition products. And this nutrition product will definitely have a good scope and it will increase.

Highlights a potential shift in farmer spending towards nutrition products, which GSP also offers, turning a risk into an opportunity.

Asked by Shivansh Singh

Sourcing challenges due to Middle East conflict Direct
See, normally we are sourcing from China. And no doubt because of this crude price, it is impacted. But there is already pass on to the customers. So from 1st April, we have increased the price from 10% to 15% already to the market.

Confirms the impact of geopolitical events on raw material costs and the company's ability to pass on these increases to customers.

Asked by Shivansh Singh

Sustainability of gross profit per kg with 10-15% price increases Direct
See, basically, one sec, I'm Shail. So, so as you said, you know, the gross profit typically would broadly be the same if we talk about per kg because whatever we are transferring as a cost will be added to our profit.

Clarifies management's expectation that gross profit margins will be maintained despite cost increases due to effective pass-through.

Asked by Avnish Burman

Revenue contribution from patented products in FY26 Direct
So in FY26, we've done almost 20% from these patented products.

Provides a key metric on the success and growing contribution of the company's innovation strategy.

Asked by Maitri Shah

Margin differential for patented products compared to off-patent technicals Direct
So, so typically, yes, it is right that the patented products have higher margin profile. So typically, the premium that we get over generics is almost 20% to 25%. So to give you an example, if say generic product is having a margin of say 35% to 40%, we are talking about gross profit margins from material consumed, then the patented product will be having say around 55% to 60% margins.

Quantifies the significant margin advantage derived from patented products, validating the company's R&D focus.

Asked by Maitri Shah

Plans for exporting patented products Direct
No, we have plans. So we have already opened a subsidiary in Brazil. And as a part of that, we are also registering our patented products which are established in India to other geographies, specifically in Brazil...

Indicates the company's international expansion strategy for its high-value patented portfolio, starting with Brazil.

Asked by Maitri Shah

Pace of product launches given the large patent pipeline Direct
So we have a team of almost 300 sales professional who are there along with 30-35 marketing professionals. So for a team of this size to do generic business and also to handle new products and do marketing activities, as per our business strategy, we feel that one or two launches in a year would justify the product's potential and we will be able to then give enough due importance for us to scale it up.

Explains the rationale behind the company's controlled pace of 1-2 product launches annually, focusing on effective market penetration and support.

Asked by Maitri Shah

2 min read 6 chapters

Detailed narrative

Introduction to GSP Crop Science and Business Model

GSP Crop Science, established in 1985, boasts over 40 years of experience with core strengths in manufacturing, R&D, and patents. The company operates two technical plants and one intermediate plant, enabling the production of numerous technical products. Its business is segmented into domestic B2B (40% of revenues), domestic B2C (40% of revenues through a network of 5,000 distributors), and exports to 37 countries (20% of revenues).

Strong Financial Performance in Q3 FY26

For the nine months ended December 31, 2025, GSP Crop Science reported a robust financial performance. The company achieved a revenue of ₹1,114 crores. EBITDA for the period stood at ₹153 crores, marking a significant 32% increase compared to the previous year. Net Profit After Tax (PAT) also saw substantial growth, reaching ₹75 crores, up 25.84% from ₹59.6 crores in the prior year, despite an exceptional provision of ₹4.5 crores for new labor wage code effects.

Innovation and Patented Products Driving Growth

GSP Crop Science's strategy centers on introducing innovative, patented products. The company holds 102 patents, with an additional 108 in the pipeline, and has successfully launched 12 patented products to date. These high-value products now contribute 20% of the company's FY26 revenues, a substantial increase from 3% three years ago. Patented products command a gross margin premium of 20-25% over generic products, with gross margins ranging from 55-60% compared to 35-40% for generics.

Managing Geopolitical and Macroeconomic Headwinds

The company has faced challenges from the Middle East conflict, leading to increased crude prices, raw material costs, and logistics expenses, with shipping costs from China reportedly doubling. To mitigate these impacts, GSP has implemented 10-15% price increases, which have been largely accepted by B2B customers. While a 2-3 month lag is anticipated for price pass-through in the B2C segment, the company maintains a 45-day inventory of imported raw materials to ensure supply stability.

Capacity Utilization and Future Revenue Potential

GSP's formulations capacity utilization is currently 30-40% due to seasonal demand, while its technical plants in Ahmedabad and Nandeshari operate at 70-75%. At peak utilization of 90%, the company projects its revenue potential to reach ₹1,900-2,000 crores. Management also indicated plans for debottlenecking existing facilities to further enhance capacity and support future growth without immediate greenfield expansion.

Strategic International Expansion and Co-Marketing Initiatives

The company is actively pursuing international expansion, having established a subsidiary in Brazil and initiated the registration process for its patented products in the region. This move aims to replicate its domestic success in new geographies. Domestically, GSP collaborates with co-marketing partners such as Rallis, Sumitomo Chemicals, Mankind Pharma, and Chambal Fertilizers, often through white-labeling arrangements, to expand the reach of its innovative products.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls